165 related articles for article (PubMed ID: 36350432)
1. HBK-15, a Multimodal Compound, Showed an Anxiolytic-Like Effect in Rats.
Lustyk K; Sałaciak K; Jakubczyk M; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Marona H; Pytka K
Neurochem Res; 2023 Mar; 48(3):839-845. PubMed ID: 36350432
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
Pytka K; Partyka A; Jastrzębska-Więsek M; Siwek A; Głuch-Lutwin M; Mordyl B; Kazek G; Rapacz A; Olczyk A; Gałuszka A; Błachuta M; Waszkielewicz A; Marona H; Sapa J; Filipek B; Wesołowska A
PLoS One; 2015; 10(11):e0142499. PubMed ID: 26554929
[TBL] [Abstract][Full Text] [Related]
3. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
[TBL] [Abstract][Full Text] [Related]
4. HBK-17, a 5-HT
Pytka K; Głuch-Lutwin M; Żmudzka E; Sałaciak K; Siwek A; Niemczyk K; Walczak M; Smolik M; Olczyk A; Gałuszka A; Śmieja J; Filipek B; Sapa J; Kołaczkowski M; Pańczyk K; Waszkielewicz A; Marona H
Front Pharmacol; 2018; 9():1146. PubMed ID: 30410441
[TBL] [Abstract][Full Text] [Related]
5. Single Administration of HBK-15-a Triple 5-HT
Pytka K; Głuch-Lutwin M; Kotańska M; Waszkielewicz A; Kij A; Walczak M
Mol Neurobiol; 2018 May; 55(5):3931-3945. PubMed ID: 28550529
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT
Sałaciak K; Malikowska-Racia N; Lustyk K; Siwek A; Głuch-Lutwin M; Kazek G; Popiół J; Sapa J; Marona H; Żelaszczyk D; Pytka K
Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451841
[TBL] [Abstract][Full Text] [Related]
7. HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice.
Pytka K; Gawlik K; Pawlica-Gosiewska D; Witalis J; Waszkielewicz A
Metab Brain Dis; 2017 Apr; 32(2):547-556. PubMed ID: 27888375
[TBL] [Abstract][Full Text] [Related]
8. HBK-14 and HBK-15, triple 5-HT
Pytka K; Socała K; Rapacz A; Nieoczym D; Pieróg M; Gryboś A; Siwek A; Waszkielewicz A; Wlaź P
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):378-385. PubMed ID: 28729118
[TBL] [Abstract][Full Text] [Related]
9. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
[TBL] [Abstract][Full Text] [Related]
10. HBK-10, A Compound with α
Lustyk K; Sałaciak K; Siwek A; Filipek B; Sapa J; Marona H; Żelaszczyk D; Pytka K
Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297368
[TBL] [Abstract][Full Text] [Related]
11. Chemically Homogenous Compounds with Antagonistic Properties at All α1-Adrenoceptor Subtypes but not β1-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats.
Pytka K; Lustyk K; Żmudzka E; Kotańska M; Siwek A; Zygmunt M; Dziedziczak A; Śniecikowska J; Olczyk A; Gałuszka A; Śmieja J; Waszkielewicz AM; Marona H; Filipek B; Sapa J; Mogilski S
Front Pharmacol; 2016; 7():229. PubMed ID: 27536240
[TBL] [Abstract][Full Text] [Related]
12. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents.
Żmudzka E; Lustyk K; Głuch-Lutwin M; Mordyl B; Zakrzewska-Sito A; Mierzejewski P; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555568
[TBL] [Abstract][Full Text] [Related]
14. Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice.
Żmudzka E; Lustyk K; Głuch-Lutwin M; Wolak M; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259325
[TBL] [Abstract][Full Text] [Related]
15. HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats.
Pytka K; Głuch-Lutwin M; Knutelska J; Jakubczyk M; Waszkielewicz A; Kotańska M
PLoS One; 2016; 11(10):e0165495. PubMed ID: 27788267
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant- and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice.
Pytka K; Żmudzka E; Lustyk K; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Barbara F
Indian J Pharmacol; 2016; 48(3):286-91. PubMed ID: 27298499
[TBL] [Abstract][Full Text] [Related]
18. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
19. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
